A., Shah, S
This table presents a clear, side-by-side evaluation of five leading Ozempic alternatives, focusing on key metrics like active ingredient, cost, dosage form, and FDA approval status
Groneberg DA, Folkerts G, Peiser C, Chung KF, Fischer A
This differs from Ozempic, which directly mimics GLP-1 and activates its receptors
Research is showing that women are driving much of that demand related to weight loss supportin fact, an August 2025 RAND report found that nearly one in five women ages 50 to 64 now take a GLP-1, with overall usage higher among women than men
however they are allowed and are very popular in countries like Korea, Taiwan, Thailand, Malaysia and the Philippines